ArticleJournal of migration and health2026
Using the Refugee Health Screener with Children and Young People Seeking Asylum and Refugees who are unaccompanied (CYPSAR-U): A mixed-methods evaluation.
Article in Journal of migration and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Children and Young People seeking asylum and refugees who are unaccompanied (CYPSAR-U) have a high risk of developing depression, anxiety, and post-traumatic stress disorder (PTSD), yet culturally sensitive screening approaches remain limited. This evaluation explored the use of the Refugee Health Screener (RHS), focusing on patient outcomes and healthcare professionals' experiences of administration. Methods: A mixed-methods service evaluation was conducted in two London-based clinics. The demographics, language, interpreter use, and RHS scores were extracted from electronic health records of 115 CYPSAR-U screened using either the RHS-13 (West London Clinic, WLC) or RHS-15 (North London Clinic, NLC) and analysed descriptively. Semi-structured discussions with 10 healthcare professionals who administered the RHS across both clinics were examined using content analysis. Results: In WLC, 48 CYPSAR-U (median age 16 years, 87.5% male) mainly originated from Eritrea (21.3%), Sudan (17.0%), and Ethiopia (12.8%), while in NLC, 67 CYPSAR-U (median age 17 years, all male) were primarily from Iran (20.9%), Sudan (20.9%), Eritrea (13.4%), and Iraq (13.4%). In the WLC RHS assessments were mostly conducted in English (52.1%) or Arabic (33.3%), with interpreters in 85.4% of consultations. At the NLC all were in English with an interpreter. At the WLC, 56% of young people scored above the clinically significant threshold of the RHS, requiring further assessment and support. At the NLC, 67% scored above the RHS clinically significant threshold. Most frequently endorsed symptoms were low mood and excessive thoughts. Clinicians reported that the RHS supported early identification, facilitated multidisciplinary communication, and helped build rapport with young people. However, challenges included linguistic and cultural barriers, interpreter variability, time pressures, and difficulties in comprehension for some CYPSAR-U. Conclusion: Within the two evaluated services, the RHS provided a structured approach to support early identification of emotional distress among CYPSAR-U and facilitated communication between healthcare professionals across services. However, challenges related to cross-cultural communication and interpretation were identified. These findings highlight the importance of using the RHS alongside clinical judgement and embedding it within trauma-informed care pathways in similar service contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.